Evaluation of efficacy and safety of PARP inhibitors in breast cancer: A systematic review and meta-analysis

BACKGROUND: Many breast cancer clinical trials with PARPi have been completed or are currently carried out, either by monotherapy or combined with chemotherapy. We aim to assess the efficacy and safety of PARPi in breast cancer patients as compared to chemotherapy. METHODS: A comprehensive literatur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Chang, Xiao-Fei, Ren, Xiao-Lu, Yang, Jie-Quan, Shi, Jian-Jun, Bai, Jun-Heng, Cui, Meng-Sheng, Dong, Wen-Wen
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8215282/
https://ncbi.nlm.nih.gov/pubmed/34130011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.05.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados